Response to Comments: MolDX: DecisionDx-Melanoma

This document is a response to comments on the MolDX DecisionDx-Melanoma (DL37748) policy, noting the comment period (06/07/2018–08/14/2018), notice period (12/26/2018–02/09/2019), and LCD finalization date (02/10/2019). The document contains no clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits; refer to the referenced LCD DL37748 for the substantive coverage criteria.